MAL and cancer: The use of strictly validated antibodies to MAL-family proteins would help avoid ostensibly contradictory results, which often arise from studies in which the expression of a biomarker in cancer samples is examined by different techniques (for instance, RNA-seq and IHC) or using different sources of primary antibodies.